Global Intravitreal Injectable Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 93

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Intravitreal Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Intravitreal Injectable size is estimated to be XX million in 2021 from USD 14120 million in 2020, with a change of XX% between 2020 and 2021. The global Intravitreal Injectable market size is expected to grow at a CAGR of 6.8% for the next five years.

Market segmentation
Intravitreal Injectable market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Anti-VEGF
    Steroids
    Others

Market segment by Application can be divided into
    Macular Degeneration
    Macular Edema
    Uveitis
    Retinal Vein Occlusion
    Others

The key market players for global Intravitreal Injectable market are listed below:
    Regeneron Pharmaceuticals (Eylea)
    Allergan
    EyePoint Pharmaceuticals
    Genentech
    Kanghong Pharmaceutical

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Intravitreal Injectable product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intravitreal Injectable, with price, sales, revenue and global market share of Intravitreal Injectable from 2019 to 2021.
Chapter 3, the Intravitreal Injectable competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravitreal Injectable breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Intravitreal Injectable market forecast, by regions, drug and disease, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Intravitreal Injectable sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Intravitreal Injectable Introduction
    1.2 Market Analysis by Drug
        1.2.1 Overview: Global Intravitreal Injectable Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Anti-VEGF
        1.2.3 Steroids
        1.2.4 Others
    1.3 Market Analysis by Disease
        1.3.1 Overview: Global Intravitreal Injectable Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Macular Degeneration
        1.3.3 Macular Edema
        1.3.4 Uveitis
        1.3.5 Retinal Vein Occlusion
        1.3.6 Others
    1.4 Global Intravitreal Injectable Market Size & Forecast
        1.4.1 Global Intravitreal Injectable Sales in Value (2016-2026))
        1.4.2 Global Intravitreal Injectable Sales in Volume (2016-2026)
        1.4.3 Global Intravitreal Injectable Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Intravitreal Injectable Production Capacity Analysis
        1.5.1 Global Intravitreal Injectable Total Production Capacity (2016-2026)
        1.5.2 Global Intravitreal Injectable Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Intravitreal Injectable Market Drivers
        1.6.2 Intravitreal Injectable Market Restraints
        1.6.3 Intravitreal Injectable Trends Analysis

2 Manufacturers Profiles
    2.1 Regeneron Pharmaceuticals (Eylea)
        2.1.1 Regeneron Pharmaceuticals (Eylea) Details
        2.1.2 Regeneron Pharmaceuticals (Eylea) Major Business
        2.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
        2.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Allergan
        2.2.1 Allergan Details
        2.2.2 Allergan Major Business
        2.2.3 Allergan Intravitreal Injectable Product and Services
        2.2.4 Allergan Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 EyePoint Pharmaceuticals
        2.3.1 EyePoint Pharmaceuticals Details
        2.3.2 EyePoint Pharmaceuticals Major Business
        2.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
        2.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Genentech
        2.4.1 Genentech Details
        2.4.2 Genentech Major Business
        2.4.3 Genentech Intravitreal Injectable Product and Services
        2.4.4 Genentech Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Kanghong Pharmaceutical
        2.5.1 Kanghong Pharmaceutical Details
        2.5.2 Kanghong Pharmaceutical Major Business
        2.5.3 Kanghong Pharmaceutical Intravitreal Injectable Product and Services
        2.5.4 Kanghong Pharmaceutical Intravitreal Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Intravitreal Injectable Sales by Manufacturer
    3.1 Global Intravitreal Injectable Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Intravitreal Injectable Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Intravitreal Injectable
    3.4 Market Concentration Rate
        3.4.1 Top 3 Intravitreal Injectable Manufacturer Market Share
        3.4.2 Top 6 Intravitreal Injectable Manufacturer Market Share
    3.5 Global Intravitreal Injectable Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Intravitreal Injectable Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Intravitreal Injectable Market Size by Region
        4.1.1 Global Intravitreal Injectable Sales in Volume by Region (2016-2026)
        4.1.2 Global Intravitreal Injectable Revenue by Region (2016-2026)
    4.2 North America Intravitreal Injectable Revenue (2016-2026)
    4.3 Europe Intravitreal Injectable Revenue (2016-2026)
    4.4 Asia-Pacific Intravitreal Injectable Revenue (2016-2026)
    4.5 South America Intravitreal Injectable Revenue (2016-2026)
    4.6 Middle East and Africa Intravitreal Injectable Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Intravitreal Injectable Sales in Volume by Type (2016-2026)
    5.2 Global Intravitreal Injectable Revenue by Type (2016-2026)
    5.3 Global Intravitreal Injectable Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Intravitreal Injectable Sales in Volume by Application (2016-2026)
    6.2 Global Intravitreal Injectable Revenue by Application (2016-2026)
    6.3 Global Intravitreal Injectable Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Intravitreal Injectable Sales by Type (2016-2026)
    7.2 North America Intravitreal Injectable Sales by Application (2016-2026)
    7.3 North America Intravitreal Injectable Market Size by Country
        7.3.1 North America Intravitreal Injectable Sales in Volume by Country (2016-2026)
        7.3.2 North America Intravitreal Injectable Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Intravitreal Injectable Sales by Type (2016-2026)
    8.2 Europe Intravitreal Injectable Sales by Application (2016-2026)
    8.3 Europe Intravitreal Injectable Market Size by Country
        8.3.1 Europe Intravitreal Injectable Sales in Volume by Country (2016-2026)
        8.3.2 Europe Intravitreal Injectable Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Intravitreal Injectable Sales by Type (2016-2026)
    9.2 Asia-Pacific Intravitreal Injectable Sales by Application (2016-2026)
    9.3 Asia-Pacific Intravitreal Injectable Market Size by Region
        9.3.1 Asia-Pacific Intravitreal Injectable Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Intravitreal Injectable Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Intravitreal Injectable Sales by Type (2016-2026)
    10.2 South America Intravitreal Injectable Sales by Application (2016-2026)
    10.3 South America Intravitreal Injectable Market Size by Country
        10.3.1 South America Intravitreal Injectable Sales in Volume by Country (2016-2026)
        10.3.2 South America Intravitreal Injectable Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Intravitreal Injectable Sales by Type (2016-2026)
    11.2 Middle East & Africa Intravitreal Injectable Sales by Application (2016-2026)
    11.3 Middle East & Africa Intravitreal Injectable Market Size by Country
        11.3.1 Middle East & Africa Intravitreal Injectable Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Intravitreal Injectable Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Intravitreal Injectable Typical Distributors
    12.3 Intravitreal Injectable Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Intravitreal Injectable Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Intravitreal Injectable Revenue by Application, (USD Million), 2021-2026
    Table 3. Regeneron Pharmaceuticals (Eylea) Basic Information, Manufacturing Base and Competitors
    Table 4. Regeneron Pharmaceuticals (Eylea) Major Business
    Table 5. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product and Services
    Table 6. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Allergan Basic Information, Manufacturing Base and Competitors
    Table 8. Allergan Major Business
    Table 9. Allergan Intravitreal Injectable Product and Services
    Table 10. Allergan Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. EyePoint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 12. EyePoint Pharmaceuticals Major Business
    Table 13. EyePoint Pharmaceuticals Intravitreal Injectable Product and Services
    Table 14. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Genentech Basic Information, Manufacturing Base and Competitors
    Table 16. Genentech Major Business
    Table 17. Genentech Intravitreal Injectable Product and Services
    Table 18. Genentech Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Kanghong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 20. Kanghong Pharmaceutical Major Business
    Table 21. Kanghong Pharmaceutical Intravitreal Injectable Product and Services
    Table 22. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Global Intravitreal Injectable Sales by Manufacturer (2019-2021e) & (K Units)
    Table 24. Global Intravitreal Injectable Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 25. Market Position of Manufacturers in Intravitreal Injectable, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 26. Global Intravitreal Injectable Production Capacity by Company, (K Units): 2020 VS 2021
    Table 27. Head Office and Intravitreal Injectable Production Site of Key Manufacturer
    Table 28. Intravitreal Injectable New Entrant and Capacity Expansion Plans
    Table 29. Intravitreal Injectable Mergers & Acquisitions in the Past Five Years
    Table 30. Global Intravitreal Injectable Sales by Region (2016-2021e) & (K Units)
    Table 31. Global Intravitreal Injectable Sales by Region (2021-2026) & (K Units)
    Table 32. Global Intravitreal Injectable Revenue by Region (2016-2021e) & (USD Million)
    Table 33. Global Intravitreal Injectable Revenue by Region (2021-2026) & (USD Million)
    Table 34. Global Intravitreal Injectable Sales by Type (2016-2021e) & (K Units)
    Table 35. Global Intravitreal Injectable Sales by Type (2021-2026) & (K Units)
    Table 36. Global Intravitreal Injectable Revenue by Type (2016-2021e) & (USD Million)
    Table 37. Global Intravitreal Injectable Revenue by Type (2021-2026) & (USD Million)
    Table 38. Global Intravitreal Injectable Price by Type (2016-2021e) & (US$/Unit)
    Table 39. Global Intravitreal Injectable Price by Type (2021-2026) & (US$/Unit)
    Table 40. Global Intravitreal Injectable Sales by Application (2016-2021e) & (K Units)
    Table 41. Global Intravitreal Injectable Sales by Application (2021-2026) & (K Units)
    Table 42. Global Intravitreal Injectable Revenue by Application (2016-2021e) & (USD Million)
    Table 43. Global Intravitreal Injectable Revenue by Application (2021-2026) & (USD Million)
    Table 44. Global Intravitreal Injectable Price by Application (2016-2021e) & (US$/Unit)
    Table 45. Global Intravitreal Injectable Price by Application (2021-2026) & (US$/Unit)
    Table 46. North America Intravitreal Injectable Sales by Country (2016-2021e) & (K Units)
    Table 47. North America Intravitreal Injectable Sales by Country (2021-2026) & (K Units)
    Table 48. North America Intravitreal Injectable Revenue by Country (2016-2021e) & (USD Million)
    Table 49. North America Intravitreal Injectable Revenue by Country (2021-2026) & (USD Million)
    Table 50. North America Intravitreal Injectable Sales by Type (2016-2021e) & (K Units)
    Table 51. North America Intravitreal Injectable Sales by Type (2021-2026) & (K Units)
    Table 52. North America Intravitreal Injectable Sales by Application (2016-2021e) & (K Units)
    Table 53. North America Intravitreal Injectable Sales by Application (2021-2026) & (K Units)
    Table 54. Europe Intravitreal Injectable Sales by Country (2016-2021e) & (K Units)
    Table 55. Europe Intravitreal Injectable Sales by Country (2021-2026) & (K Units)
    Table 56. Europe Intravitreal Injectable Revenue by Country (2016-2021e) & (USD Million)
    Table 57. Europe Intravitreal Injectable Revenue by Country (2021-2026) & (USD Million)
    Table 58. Europe Intravitreal Injectable Sales by Type (2016-2021e) & (K Units)
    Table 59. Europe Intravitreal Injectable Sales by Type (2021-2026) & (K Units)
    Table 60. Europe Intravitreal Injectable Sales by Application (2016-2021e) & (K Units)
    Table 61. Europe Intravitreal Injectable Sales by Application (2021-2026) & (K Units)
    Table 62. Asia-Pacific Intravitreal Injectable Sales by Region (2016-2021e) & (K Units)
    Table 63. Asia-Pacific Intravitreal Injectable Sales by Region (2021-2026) & (K Units)
    Table 64. Asia-Pacific Intravitreal Injectable Revenue by Region (2016-2021e) & (USD Million)
    Table 65. Asia-Pacific Intravitreal Injectable Revenue by Region (2021-2026) & (USD Million)
    Table 66. Asia-Pacific Intravitreal Injectable Sales by Type (2016-2021e) & (K Units)
    Table 67. Asia-Pacific Intravitreal Injectable Sales by Type (2021-2026) & (K Units)
    Table 68. Asia-Pacific Intravitreal Injectable Sales by Application (2016-2021e) & (K Units)
    Table 69. Asia-Pacific Intravitreal Injectable Sales by Application (2021-2026) & (K Units)
    Table 70. South America Intravitreal Injectable Sales by Country (2016-2021e) & (K Units)
    Table 71. South America Intravitreal Injectable Sales by Country (2021-2026) & (K Units)
    Table 72. South America Intravitreal Injectable Revenue by Country (2016-2021e) & (USD Million)
    Table 73. South America Intravitreal Injectable Revenue by Country (2021-2026) & (USD Million)
    Table 74. South America Intravitreal Injectable Sales by Type (2016-2021e) & (K Units)
    Table 75. South America Intravitreal Injectable Sales by Type (2021-2026) & (K Units)
    Table 76. South America Intravitreal Injectable Sales by Application (2016-2021e) & (K Units)
    Table 77. South America Intravitreal Injectable Sales by Application (2021-2026) & (K Units)
    Table 78. Middle East & Africa Intravitreal Injectable Sales by Country (2016-2021e) & (K Units)
    Table 79. Middle East & Africa Intravitreal Injectable Sales by Country (2021-2026) & (K Units)
    Table 80. Middle East & Africa Intravitreal Injectable Revenue by Country (2016-2021e) & (USD Million)
    Table 81. Middle East & Africa Intravitreal Injectable Revenue by Country (2021-2026) & (USD Million)
    Table 82. Middle East & Africa Intravitreal Injectable Sales by Type (2016-2021e) & (K Units)
    Table 83. Middle East & Africa Intravitreal Injectable Sales by Type (2021-2026) & (K Units)
    Table 84. Middle East & Africa Intravitreal Injectable Sales by Application (2016-2021e) & (K Units)
    Table 85. Middle East & Africa Intravitreal Injectable Sales by Application (2021-2026) & (K Units)
    Table 86. Direct Channel Pros & Cons
    Table 87. Indirect Channel Pros & Cons
    Table 88. Intravitreal Injectable Typical Distributors
    Table 89. Intravitreal Injectable Typical Customers
List of Figures
    Figure 1. Intravitreal Injectable Picture
    Figure 2. Global Intravitreal Injectable Sales Market Share by Type in 2020
    Figure 3. Anti-VEGF
    Figure 4. Steroids
    Figure 5. Others
    Figure 6. Global Intravitreal Injectable Sales Market Share by Application in 2020
    Figure 7. Macular Degeneration
    Figure 8. Macular Edema
    Figure 9. Uveitis
    Figure 10. Retinal Vein Occlusion
    Figure 11. Others
    Figure 12. Global Intravitreal Injectable Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 13. Global Intravitreal Injectable Market Size and Forecast (2016-2026) & (USD Million)
    Figure 14. Global Intravitreal Injectable Sales (2016-2026) & (K Units)
    Figure 15. Global Intravitreal Injectable Price by Type (2016-2026) & (US$/Unit)
    Figure 16. Global Intravitreal Injectable Production Capacity (2016-2026) & (K Units)
    Figure 17. Global Intravitreal Injectable Production Capacity by Geographic Region: 2020 VS 2021
    Figure 18. Intravitreal Injectable Market Drivers
    Figure 19. Intravitreal Injectable Market Restraints
    Figure 20. Intravitreal Injectable Market Trends
    Figure 21. Global Intravitreal Injectable Sales Market Share by Manufacturer in 2020
    Figure 22. Global Intravitreal Injectable Revenue Market Share by Manufacturer in 2020
    Figure 23. Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 24. Top 3 Intravitreal Injectable Manufacturer (Revenue) Market Share in 2020
    Figure 25. Top 6 Intravitreal Injectable Manufacturer (Revenue) Market Share in 2020
    Figure 26. Global Intravitreal Injectable Sales Market Share by Region (2016-2026)
    Figure 27. Global Intravitreal Injectable Revenue Market Share by Region (2016-2026)
    Figure 28. North America Intravitreal Injectable Revenue (2016-2026) & (USD Million)
    Figure 29. Europe Intravitreal Injectable Revenue (2016-2026) & (USD Million)
    Figure 30. Asia-Pacific Intravitreal Injectable Revenue (2016-2026) & (USD Million)
    Figure 31. South America Intravitreal Injectable Revenue (2016-2026) & (USD Million)
    Figure 32. Middle East & Africa Intravitreal Injectable Revenue (2016-2026) & (USD Million)
    Figure 33. Global Intravitreal Injectable Sales Market Share by Type (2016-2026)
    Figure 34. Global Intravitreal Injectable Revenue Market Share by Type (2016-2026)
    Figure 35. Global Intravitreal Injectable Price by Type (2016-2026) & (US$/Unit)
    Figure 36. Global Intravitreal Injectable Sales Market Share by Application (2016-2026)
    Figure 37. Global Intravitreal Injectable Revenue Market Share by Application (2016-2026)
    Figure 38. Global Intravitreal Injectable Price by Application (2016-2026) & (US$/Unit)
    Figure 39. North America Intravitreal Injectable Sales Market Share by Type (2016-2026)
    Figure 40. North America Intravitreal Injectable Sales Market Share by Application (2016-2026)
    Figure 41. North America Intravitreal Injectable Sales Market Share by Country (2016-2026)
    Figure 42. North America Intravitreal Injectable Revenue Market Share by Country (2016-2026)
    Figure 43. United States Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Canada Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Mexico Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Europe Intravitreal Injectable Sales Market Share by Type (2016-2026)
    Figure 47. Europe Intravitreal Injectable Sales Market Share by Application (2016-2026)
    Figure 48. Europe Intravitreal Injectable Sales Market Share by Country (2016-2026)
    Figure 49. Europe Intravitreal Injectable Revenue Market Share by Country (2016-2026)
    Figure 50. Germany Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. France Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. United Kingdom Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Russia Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Italy Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Asia-Pacific Intravitreal Injectable Sales Market Share by Region (2016-2026)
    Figure 56. Asia-Pacific Intravitreal Injectable Sales Market Share by Application (2016-2026)
    Figure 57. Asia-Pacific Intravitreal Injectable Sales Market Share by Region (2016-2026)
    Figure 58. Asia-Pacific Intravitreal Injectable Revenue Market Share by Region (2016-2026)
    Figure 59. China Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Japan Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Korea Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. India Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Southeast Asia Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Australia Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South America Intravitreal Injectable Sales Market Share by Type (2016-2026)
    Figure 66. South America Intravitreal Injectable Sales Market Share by Application (2016-2026)
    Figure 67. South America Intravitreal Injectable Sales Market Share by Country (2016-2026)
    Figure 68. South America Intravitreal Injectable Revenue Market Share by Country (2016-2026)
    Figure 69. Brazil Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Argentina Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Middle East & Africa Intravitreal Injectable Sales Market Share by Type (2016-2026)
    Figure 72. Middle East & Africa Intravitreal Injectable Sales Market Share by Application (2016-2026)
    Figure 73. Middle East & Africa Intravitreal Injectable Sales Market Share by Country (2016-2026)
    Figure 74. Middle East & Africa Intravitreal Injectable Revenue Market Share by Country (2016-2026)
    Figure 75. Turkey Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Egypt Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Saudi Arabia Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. South Africa Intravitreal Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical

Related Reports

Global Intravitreal Injectable Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Intravitreal Injectable Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Intravitreal Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Intravitreal Injectable Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Intravitreal Injectable Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.

Global Intravitreal Injectable Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Intravitreal Injectable Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Intravitreal Injectable market size was valued at USD 14950 million in 2023 and is forecast to a readjusted size of USD 23690 million by 2030 with a CAGR of 6.8% during review period.

Global Intravitreal Injectable Supply, Demand and Key Producers, 2024-2030

Global Intravitreal Injectable Supply, Demand and Key Producers, 2024-2030

date 27 Feb 2024

date Pharma & Healthcare

The global Intravitreal Injectable market size is expected to reach $ 23690 million by 2030, rising at a market growth of 6.8% CAGR during the forecast period (2024-2030).

Product Tags

intravitreal injectable

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>